Diamyd Medical AB (OTC:DMYDY) and its CEO parted ways after the chief executive had a falling out with the company’s board.
Elisabeth Lindner left her position with the company "due to disagreement with the Board concerning certain important matters," the company said in prepared remarks.
Diamyd replaced Lindner with excecutive VP Peter Zerhouni, who has been involved in "all aspects of the company since 2006, including a key role in driving the company’s business and clinical trials forward," according to the company.
Lindner had a role in its progress through the Phase III program with its drug Diamyd in recent-onset type 1 diabetes, according to the company.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- NIH taps new "Council of Councils" members
The National Institutes of Health announced the appointments of 20 individuals to the NIH Council of Councils. The council was established by the NIH Reform Act of 2006 to advise the NIH Director on cutting edge, trans-NIH priorities and matters related to policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), also established by the act. The council is made up of 27 members selected from the NIH Institute and Center (IC) advisory councils and the Council of Public Representatives, an advisory committee to the NIH Office of the Director.
- SynapDx adds Thomas Mac Mahon to board
SynapDx Corp. announced that Thomas Mac Mahon has joined its board of directors. Thomas Mac Mahon was President and CEO and a member of the Executive and Management Committees of Laboratory Corp. of America (LabCorp) from January 1997 until his retirement at the end of 2006.
- Biosign names Colley Clark CFO
Biosign Technologies Inc.(TSXV:BIO) announces the appointment of Colley Clarke as interim CFO. Clarke is known for his financial leadership of TSX Venture Exchange and NASDAQ listed companies in the technology, media and communications industries. He will oversee Biosign’s finance, accounting and investor relations functions, while focusing on the company’s growth and profitability. Reporting to President and CEO, Dr. Radu Leca, Clarke will be involved in strategic planning, operations and executive recruiting.
- Novavax makes new senior management appointments
Novavax Inc. (NSDQ:NVAX) announced the appointments of Louis Fries III, M.D., as VP, Clinical and Medical Affairs, and Jane Halpern, Ph.D., as VP of Regulatory Affairs. Before joining Novavax, Dr. Fries was Director, Global Clinical Development at GSK Biologicals, North America and Dr. Halpern was Staff Scientist and Regulatory Affairs Specialist at the Vaccine Research Center of the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health.
- Harlan Labs taps Manuela Leone to head contract research services
Harlan Laboratories Inc., a leading contract research organization and research models and services company, announces that Dr. Manuela Leone has been recruited to replace Dr. Kuno Sommer as president of contract research services (CRS) for the company.
- Donald Fowler joins Toshiba America Medical Systems as GM and aenior VP
Toshiba America Medical Systems Inc. announced that Donald L. Fowler has been named general manager and senior VP. In this role, Fowler is responsible for driving the growth of Toshiba’s multi-modality business in the United States. He will oversee sales, marketing, service, finance, HR and IT functions.
- IntraPace names Bart Bandy chief commercial officer
IntraPace Inc. announced the appointment of Bart Bandy as its Chief Commercial Officer. In this role, Bandy will oversee marketing, business development, and commercialization of the company’s products.
- Sue Pierce named product dev. VP at GenMark
GenMark Diagnostics Inc. (NSDQ:GNMK) announced that it has appointed Sue Pierce as VP, Product Development.
- Jeff Williams joins Life Magnetics from Accuri
Jeff Williams has joined a University of Michigan medical device spinoff. Williams agreed to become the new CEO of Ann Arbor-based Life Magnetics after shepherding Scio Township-based Accuri Cytometers to a blockbuster sale in February to New Jersey-based medical devices giant Becton, Dickinson and Co., writes AnnArbor.com
- Invacare announces changes for regulatory leadership
Invacare Corp. (NYSE:IVC) announced that Doug Newlin, Senior VP of Global Engineering, will assume leadership of the Company’s regulatory team in place of Colleen Craven, Chief Compliance Officer, who has resigned for personal reasons.